Tag: Eris Lifesciences

  • Eris Lifesciences strengthens pulse with Murari Ranganathan’s appointment

    Eris Lifesciences strengthens pulse with Murari Ranganathan’s appointment

    MUMBAI: Eris Lifesciences is set to beat stronger in the cardiometabolic space with the appointment of Murari Ranganathan as president, cardiometabolic business. Stepping into the Mumbai office, he will spearhead the company’s Anti-Diabetes and Cardiology divisions, two of Eris’ flagship verticals.

    Eris Lifesciences chairman and managing director Amit Bakshi said, “Murari’s expertise will be invaluable in strengthening our position in the cardiometabolic segment. We’re thrilled to have him on board and look forward to the milestones ahead.”

    On his appointment, Ranganathan said, “Eris Lifesciences is the youngest player among the top 20 pharmaceutical companies in India, and its dynamic, entrepreneurial culture is truly inspiring. I look forward to working with the team to set new benchmarks in disease management and patient care.”

    Ranganathan brings over two decades of industry experience, having previously served as commercial director at Abbott India Ltd, where he led women’s health, metabolics, and international business. His career spans leadership roles at Baxter, Novo Nordisk, and Torrent Pharma, and he holds a Postgraduate Diploma in Marketing from St. Joseph College of Business Administration, Bangalore.

    With this strategic move, Eris Lifesciences is set to fortify its presence in one of India’s fastest-growing healthcare segments, keeping its commitment to innovation and patient well-being at the heart of its expansion.

  • Eris Lifesciences appoints Boman Irani as Circa’s brand ambassador

    Eris Lifesciences appoints Boman Irani as Circa’s brand ambassador

    MUMBAI: Eris Lifesciences has announced an association with the well-known theatre and film actor, Boman Irani, for their Circa range of devices. The association is aimed at highlighting the importance of an accurate and validated BP monitoring device.

    The focus of the campaign is to encourage hypertensive patients to measure their blood pressure at home using a validated device while making an appeal to share their readings with the doctor. The campaign theme #ShareYourPressure urges users to stop worrying about getting a false reading and trust the device to share their pressure.

    Boman Irani said, “It gives me immense pleasure to start this journey with Circa. For blood pressure management, the latest norms require a person to monitor it at least 2 times a day in the morning and evening. With technology advancing manifolds, it is only important for us to bring the same into our healthcare systems and adopt validated devices that can provide timely updates when required.”

    The campaign will go live on social media channels this week in the form of short videos.

    Eris Lifesciences Chairman and MD Amit Bakshi said, “Hypertension therapy is our second largest therapy and with cardiovascular being the No. 1 Chronic therapy, we are upping our ante by closing the loop with one of the most validated devices for blood pressure management. We have world-class data in the form of ‘India Heart Study’ conducted on the same ‘Circa’ device further validating our commitment to Hypertension therapy.

    "With Boman Irani on board, we feel this partnership with the brand will increase awareness around Home Blood pressure monitoring (HBPM) and bring more people to target Blood pressure.”

    The coronavirus outbreak has highlighted that patients with co-morbidities, E.g. Hypertension, are vulnerable to developing serious complications. Hence, an accurate measurement of blood pressure at home becomes extremely crucial. Any error in the measurement of blood pressure because of non-validated devices can put the life of the patient at risk.